Blinklab Limited (Asx:Bb1)

Blinklab Limited (Asx:Bb1) company information, Employees & Contact Information

BlinkLab Limited (ASX.BB1), a company founded by neuroscientists at Princeton University, over the past several years has fully developed a smartphone based diagnostic platform for autism, ADHD, schizophrenia, and other neurodevelopmental conditions. Our most advanced product is an autism diagnostic test that leverages the power of smartphones, AI and machine learning to deliver screening tests specifically designed for children as young as 18 months old. This marks a significant advancement, considering traditional diagnoses typically occur around five years of age, often missing the crucial early window for effective intervention. BlinkLab is led by an experienced management team and directors with a proven track record in building companies and vast knowledge in digital healthcare, computer vision, AI and machine learning. Our Scientific Advisory Board consists of leading experts in the field of autism and brain development allowing us to bridge most advanced technological innovations with groundbreaking scientific research.

Company Details

Employees
27
Founded
-
Address
Oude Delft 37, Delft,zuid-Holland 2611 Bb,netherlands
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
Sydney.
HQ
Delft, Zuid-Holland
Looking for a particular Blinklab Limited (Asx:Bb1) employee's phone or email?

Blinklab Limited (Asx:bb1) Questions

News

We're Not Very Worried About BlinkLab's (ASX:BB1) Cash Burn Rate - Yahoo Finance

We're Not Very Worried About BlinkLab's (ASX:BB1) Cash Burn Rate Yahoo Finance

BlinkLab expands US clinical trial network with University of Missouri’s Thompson Center - BiotechDispatch

BlinkLab expands US clinical trial network with University of Missouri’s Thompson Center BiotechDispatch

BlinkLab Completes First Patient Test for US Autism Diagnostic Study - Investing News Network

BlinkLab Completes First Patient Test for US Autism Diagnostic Study Investing News Network

When Will BlinkLab Limited (ASX:BB1) Breakeven? - Yahoo Finance

When Will BlinkLab Limited (ASX:BB1) Breakeven? Yahoo Finance

BlinkLab Limited's (ASX:BB1) Profit Outlook - simplywall.st

BlinkLab Limited's (ASX:BB1) Profit Outlook simplywall.st

Diagnostics company BlinkLab seeks funds ahead of FDA submission - AFR

Diagnostics company BlinkLab seeks funds ahead of FDA submission AFR

North Shore Pediatric Therapy in Chicago Joins BlinkLab’s US Registrational Study - Investing News Network

North Shore Pediatric Therapy in Chicago Joins BlinkLab’s US Registrational Study Investing News Network

Blinklab (ASX:BB1): Is this exciting company the next ResApp? - Stocks Down Under

Blinklab (ASX:BB1): Is this exciting company the next ResApp? Stocks Down Under

BlinkLab engages leading autism research centre for main study phase of US diagnostic trial - BiotechDispatch

BlinkLab engages leading autism research centre for main study phase of US diagnostic trial BiotechDispatch

BlinkLab Completes First Patient Test for US Autism Diagnostic Study - Nasdaq

BlinkLab Completes First Patient Test for US Autism Diagnostic Study Nasdaq

Blinklab Limited Announces Quotation of New Securities on ASX - TipRanks

Blinklab Limited Announces Quotation of New Securities on ASX TipRanks

Break it Down: BlinkLab’s positive pivot into US market path - Stockhead

Break it Down: BlinkLab’s positive pivot into US market path Stockhead

Improving kids autism and ADHD diagnoses through BlinkLab collaboration - Monash University

Improving kids autism and ADHD diagnoses through BlinkLab collaboration Monash University

BlinkLab Limited (ASX: BB1) – Trading Halt - Investing News Network

BlinkLab Limited (ASX: BB1) – Trading Halt Investing News Network

Blinklab Limited Issues Quoted Securities in Compliance with Corporations Act - TipRanks

Blinklab Limited Issues Quoted Securities in Compliance with Corporations Act TipRanks

Is BlinkLab (ASX:BB1) In A Good Position To Deliver On Growth Plans? - Yahoo Finance

Is BlinkLab (ASX:BB1) In A Good Position To Deliver On Growth Plans? Yahoo Finance

Large-Scale Study Validates and Enhances BlinkLab’s Accuracy in Detecting Autism in Children - Investing News Network

Large-Scale Study Validates and Enhances BlinkLab’s Accuracy in Detecting Autism in Children Investing News Network

Blinklab Signs Partnership for Clinical Trial with European INTER-PSY, Supporting US and EU Regulatory Approval and Future Market Adoption - Investing News Network

Blinklab Signs Partnership for Clinical Trial with European INTER-PSY, Supporting US and EU Regulatory Approval and Future Market Adoption Investing News Network

BlinkLab Limited: Transforming Mental Healthcare through Mobile-based AI App - Investing News Network

BlinkLab Limited: Transforming Mental Healthcare through Mobile-based AI App Investing News Network

BlinkLab Limited - Investing News Network

BlinkLab Limited Investing News Network

Blinklab digital app could change how autism is diagnosed - BioWorld MedTech

Blinklab digital app could change how autism is diagnosed BioWorld MedTech

BlinkLab capital raise to advance AI-powered diagnostics for autism and ADHD trials - BiotechDispatch

BlinkLab capital raise to advance AI-powered diagnostics for autism and ADHD trials BiotechDispatch

BlinkLab (ASX:BB1) Launches Dx 1 for Neuro Diagnostics - Kalkine Media

BlinkLab (ASX:BB1) Launches Dx 1 for Neuro Diagnostics Kalkine Media

Blinklab (ASX:BB1) is gearing up for FDA approval and commercial rollout - Stocks Down Under

Blinklab (ASX:BB1) is gearing up for FDA approval and commercial rollout Stocks Down Under

BlinkLab launches first US sites for autism study - The Australian

BlinkLab launches first US sites for autism study The Australian

AusBiotech 2024: BlinkLab - Western Australian Government

AusBiotech 2024: BlinkLab Western Australian Government

BlinkLab platform could transform ADHD/autism diagnosis - The Australian

BlinkLab platform could transform ADHD/autism diagnosis The Australian

Analysts put 430% upside on Blinklab shares - The Australian

Analysts put 430% upside on Blinklab shares The Australian

June Grant, Architect - PBS

June Grant, Architect PBS

Can BlinkLab’s autism diagnosis tool replicate the huge success of ResApp? - Stockhead

Can BlinkLab’s autism diagnosis tool replicate the huge success of ResApp? Stockhead

ASX Health Stocks: HITIQ secures US patent; BlinkLab joins forces in Europe to transform ADHD diagnosis - Stockhead

ASX Health Stocks: HITIQ secures US patent; BlinkLab joins forces in Europe to transform ADHD diagnosis Stockhead

How to buy Blinklab (BB1) shares in Australia - Finder.com.au

How to buy Blinklab (BB1) shares in Australia Finder.com.au

Top Blinklab Limited (Asx:Bb1) Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant